TAI'AN, China, Nov. 15, 2010 /PRNewswire-Asia-FirstCall/ --
China Biologic Products, Inc. (Nasdaq: CBPO) ("China Biologic," or
the "Company"), a leading plasma-based biopharmaceutical company in
China, today announced that the
Company's management will present at the upcoming Brean Murray,
Carret & Co. 2010 China Growth Conference.
|
Date:
|
November 17,
2010
|
|
|
Time:
|
09:20
a.m.
EST
|
|
|
Presenter:
|
Ming
Yin, Vice
President - Finance
|
|
|
Location:
|
Track II
|
|
|
The Millennium Broadway
Hotel
|
|
|
145 West 44th
Street
|
|
|
New York, New York
10036
|
|
|
|
The Brean Murray, Carret & Co. 2010 China Growth Conference
is a two-day conference (November 17-18,
2010) that consists of 25-minute presentation slots followed
by 10-minutes of open floor Q&A sessions with institutional
investors. Senior management of presenting companies, industry
experts, and institutional investors will receive a unique and
comprehensive view of China from a
global perspective. China Biologic's management will be available
for 1x1 meetings before and after the Company's presentation.
About China Biologic Products, Inc.
China Biologic Products, Inc. (the "Company"), through its
indirect majority-owned subsidiaries, Shandong Taibang Biological
Products Co., Ltd. and Guiyang Dalin Biological Technologies Co.,
Ltd, and its equity investment in Xi'an Huitian Blood Products Co.,
Ltd., is currently one of the leading plasma-based
biopharmaceutical company in China. The Company is a fully integrated
biological products company with plasma collection, production and
manufacturing, research and development and commercial operations.
The Company's plasma-based biopharmaceutical products are
irreplaceable during medical emergencies, and are used for the
prevention and treatment of various diseases. The Company sells its
products to hospitals and other healthcare facilities in
China.
|
Company
Contact:
|
|
|
Mr. Ming Yin
|
|
|
Vice President -
Finance
|
|
|
China Biologic Products,
Inc.
|
|
|
Tel:
+86-851-3605846
|
|
|
Email:
IR@chinabiologic.com
|
|
|
www.chinabiologic.com
|
|
|
|
|
Investor
Relations Contact:
|
|
|
Mr. Crocker Coulson,
President
|
|
|
CCG Investor
Relations
|
|
|
Phone: +1 (646)
213-1915
|
|
|
Email:
crocker.coulson@ccgir.com
|
|
|
www.ccgirasia.com
|
|
|
SOURCE China Biologic Products, Inc.